Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
Tekmira Enters Phase II Ebola Clinical Study in Sierra Leone Medical Countermeasures March 11, 2015 …
New Insights on Early Stages of Bubonic Plague Infections Medical Countermeasures February 12, 2015 …